These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13179818)

  • 1. [Body constitution of the prostatic].
    ALKEN CE; REUTER UH; OTT B
    Z Urol; 1954; 47(1):1-13. PubMed ID: 13179818
    [No Abstract]   [Full Text] [Related]  

  • 2. [CONSTITUTIONAL STUDIES ON TUMOR OF THE PROSTATE. I. ON THE MEASUREMENT OF CONSTITUTION].
    OGAWA M
    Hinyokika Kiyo; 1964 Oct; 10():677-85. PubMed ID: 14224745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the causal genesis of prostatic hypertrophy. I].
    Kaufmann J
    Z Urol Nephrol; 1968 Mar; 61(3):171-84. PubMed ID: 4173128
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
    Rohrmann S; Platz EA; Smit E; Giovannucci E
    J Urol; 2004 Aug; 172(2):779. PubMed ID: 15247791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical, biochemical and histologic aspects of iontophoretic magnesium therapy for prostatic hypertrophy].
    FERULANO O
    G Ital Chir; 1954 Jul; 10(7):537-66. PubMed ID: 13200849
    [No Abstract]   [Full Text] [Related]  

  • 6. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
    Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
    J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of Prostane in experimental prostatic hyperplasia in rats.
    Mitra SK; Sundaram R; Mohan AR; Gopumadhavan S; Venkataranganna MV; Venkatesha U; Seshadri SJ; Anturlikar SD
    Asian J Androl; 1999 Dec; 1(4):175-9. PubMed ID: 11225890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electron-microscopic studies of the normal prostate, prostatic hypertrophy and prostatic carcinoma].
    Kirchheim D; Bacon RL
    Urologe; 1968; 7(5):292-305. PubMed ID: 4178530
    [No Abstract]   [Full Text] [Related]  

  • 10. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives].
    Desgrandchamps F; Tatoud R; Cussenot O; Teillac P; Le Duc A
    Prog Urol; 1992 Dec; 2(6):1031-44. PubMed ID: 1284554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body size and prostate cancer.
    Harv Mens Health Watch; 1999 Mar; 3(8):7. PubMed ID: 10066315
    [No Abstract]   [Full Text] [Related]  

  • 13. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
    J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of benign prostate hypertrophy in Calabar.
    Umezurike BI; Ekanem TB; Eluwa MA; Etta KK; Udo-Affah GA; Aligwekwe AU
    Niger Postgrad Med J; 2006 Sep; 13(3):236-9. PubMed ID: 17278305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinoma.
    McNeal JE
    Semin Ultrasound CT MR; 1988 Oct; 9(5):329-34. PubMed ID: 2483527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prostatic massage on acid phosphatase in patients with and without benign prostatic hypertrophy.
    Glazener CM; Pringle R
    Br J Clin Pract; 1982 Sep; 36(9):305-6. PubMed ID: 6185127
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics of bladder urothelial tumors in male patients--the influences of benign prostatic hyperplasia/benign prostatic enlargement.
    Zhang NZ; Chen J; Ma L; Xu ZS
    Urol Oncol; 2012 Sep; 30(5):646-51. PubMed ID: 20870428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of the physical properties of the prostate (first report)--prostatic pressure coefficient and presumed circle area ratio in benign prostatic hypertrophy].
    Ohnishi K
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1377-87. PubMed ID: 2433484
    [No Abstract]   [Full Text] [Related]  

  • 20. [The problem of prostate hypertrophy. IV. Therapy of prostate hypertrophy].
    RICHTER WH
    Z Urol; 1956; 49(8):487-98. PubMed ID: 13393332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.